The beha vior of adenoid cystic carcinoma (ACC) of the salivary glands has been show n to be unp redi ctabl e in term s of local and distant sp read and mortality. We retrospectively studied 35 ope rations in 34 patient s who had had a path ologic diagnosis ofA CC ofthe salivary glands and who had bee n treated over a 20 -yea r period andfollow edfor a m inimum of 10 ye ars. We analyzed the effect that different f actors had on outco mes. The site of orig in appeared to be an important f acto r in surviva l rates; survival amo ng patients with tum ors tha t had originated in the parotid gland was fa irly good, while surv ival am ong those with tumors that orig inated in the min or salivary glands was significantly worse. TNM stag ing was anoth er significant fa ctor in survival. Oth er poor prognostic indicators were local sp read, nodal positivity, distant meta sta sis, and local and regional recurrence. Radiation and chemo the rapy did not app ear to be benefi cial fo r patients with advanced diseas e. We recommend radi cal surgery with complete resection for all patients with ACC of the salivary glands and a careful assessm ent of the neck in patients with minor salivary gland tumors.
distant metastasis. ACC is asso ciated with a high mort ality rate, and it often recur s after prolon ged periods of time. On the other hand , some patient s survive for a con siderable length of time even in the face of distant metastasis. ' Several factors have been considered indicative ofa poor prognosis in patients with ACC , including an advanced tum or stage.v' a solid histologic type,5.6 the presence of nodal metastasis.' and the presence of positive margins and perin eural spread. Many studies have lacked a satisfactory follow-up period, a fact that may account fort he differenc es in prognosis among them. In an attempt to clarify some of the inconsistencies regarding the behavior of ACC, we studied a series of patient s who had been follo wed for 10 to 30 years.
Patients and methods
From January 1970 throu gh December 1989,40 patients withACC of the salivary glands were treated at the Beilinson Campus of the Rabin Medical Center in Petah-Tikva , Israel. Patient s who had been treated within the previou s 10 years were excluded from the study to allow for at least 10 years of follow-up.
Sufficient data for inclu sion in this study were available for 34 patients-17 men and 17 women, aged 22 to 80 years (mean: 57.7). Th e 34 patients underwent a total of 35 operations. Mo st of these patients had superficial parotid lesions and they had undergone a superficial parotid ectomy; those who had tumors that involved the deep lobe underwent a total parotidectomy. Preservation of the facia l nerve was attempted in all cases unless the ner ve was cle arly involved in the cancerous process. Submandibular and minor salivary gland tumors were resected with the goa l of achieving adequ ate margins of rese ction. Lymph node dissection was perform ed only on patient s who were lymph aden opathy-positive at present ation . Follow-up ranged from 10 to 30 years (mean: 15).
We compiled data on factors that might influence survival, includingTNM stage, local spread (including perineural and bone invasion), regional and distant spread, type of treat- Th e impact of these factors on outcome was ev aluated by multiple logistic regression , and the different cate gori es were co mpared by a chi-square test performed with Sigma-Stat Sta tistical Soft ware (SPSS; Ch icago). Linear variables we re analyzed by linear corre latio n. Kaplan-M eier curves were generated for disease-free survival.
Results
Th e most common sites of tumor origin were the paro tid gland (35.3%) and the minor salivary glands of the hard palate ( 17.6%) (table 1) . Priorto surge ry, the most comm on co mplaint at present ation (65.7%) and the most co mmon sign on physical examin ation (77. 1%) was a lump in the invol ved gland. Oth er clinical compl aints and physical signs were see n much less often; the most co mmon of these were local pain and oral ulcer (8.6% each).
Of the 34 patient s, 22 (64.7%) prese nted with ear ly cance rs (T I or T2 ), and the rem aining 12 (35.3%) had local or regional adva nced disease (T3 or T4 ) (table 2) .
Onl y 4 patient s ( 11.8%) had regio nal lymph node metastasis at the time of surge ry (table 3) , and their treatm ent inclu ded neck dissection .Th ree patients (8.8%) had distant metastasis. In light of the sma ll numbers of patients with reg ional and distant metastases at prese ntation, the effec t of metastasis on survival could not be eval uate d.
Histology. Histologic subtyping was ava ilable for 2 I patients, 4 of whom had predominantly solid tumors . This small number preclud ed us from making any histologic correlatio ns with any of the study parameters.
Treatment. All patient s underwent surgical resec tion of their primary tu mor, with the exce ptio n of I patient who had a dis tant metastasis at present ation ; this patient was treated with co mbined radio-and chemotherapy. Two patient s underwent 2 operations eac h. Ninetee n patients (55.9%) rece ived adju vant radiotherapy in additio n to surgical excision; 6 of the 19 also received concomitant chemotherapy . Recurrence and metastasis. Regional recurrence occurred in 12 of the 34 patient s (35.3%); 8 of these recurrenc es developed durin g follow-up. Distant meta stasis developed in IS patient s (44. 1%); 3 metastases were detected at presentation , and 12 developed durin g followup. All but I of the patien ts with regional recurrenc e and all patient s with distant metastasis died of disease within 3 yea rs of diagnosis (survival: 8.3 and 0%, respecti vely). All patient s who presented with regional metastasis died of disease during follow-up. Th e mean length of tim e to the developme nt of regional recurrence (10.0 yr) was similar to the mean length of time to the deve lopme nt of distant metastasis (9.7 yr); in both cases, the range was I to 30 years. Only 9 of the 20 patients (45 .0%) who developed a reg ional recurrence or distant metastasis durin g follow-up did so dur ing the first 10 yea rs of follow -up; the rema ining II patients (55.0%) developed theirrec urrence or metastasis between 10 and 20 years of follow -up.
Survival. Durin g follo w-up , 19 of the 34 patients (55 .9%) died of their disease and I patien t (2.9%) remained alive with disease. Of the rem ainin g 14 patient s, 10 (29.4%) were alive with no ev idence of disease and 4 ( 11.8%) had died of other ca uses with no evide nce of disease; of the latter 4 patients, 2 died 8 years followi ng treatment and 2 died 2 years after treatment. Disease-free surv ival was similar to overall survival-4 1.2 and 32.3 %, respe ctively (ta ble 4) .
Riskfactors. Analysis of different risk fac tors revealed that the site and size of the tumor had a sig nificant effect on survival, as did surgical margins:
Tumor site. Patient s whose tumors orig inated in the parotid gland (n = 12) had a significantly better survival than those whose primary tumors arose in the mi nor salivary glands (n = 15) (tab le 5). Th e tumo rs in the rem aining 7 patient s had origi nated in the maxillary sinus, base of the tong ue, or ethmoid sinus.
Tumor stage. Patient s with larger tumors had a higher mort ality rate (p = 0.03) ( 
Discussio n
In a study of a large series of pa tients with ACC, Ford ice et al re ported that neith er tumor site nor tumor stage had a sig nifica nt effect on survival." However, considering the limited length of fo llow-up in that st udy (as littl e as 2 yr in some cases) and the te nde ncy of ACC to recur late, their co nc lusions should no t be co nsidered defi nitive . Th e TNM stage of ACC at presentation ap pears to be re levant to survival. We dem onstrated a linear increase in survival with decreasi ng tum or stage. We co uld not show a correlation between nodal stagi ng and distan t me tas tasis because of the sma ll nu mb er of patients, but we did find a 100 % mortality in cases of lymph aden opath y at present ation. Fordice et al claime d that it was nodal positivity rat her than nodal stage that is the im portant factor, and we tend to ag ree. "
Local sprea d devel oped in 12 of our patients-3 of the 12 (25. 0%) who had a parotid tumor and 9 of the 22 (40 .9%) who had a mino rsalivary glan d tum or.T he grea ter prop en sity of minor sa livary gland tum ors to spread in fasc ial pla nes and nerves makes complete surg ica l excision mu ch more diffic ult. T he main de ter minant of survival is prob abl y not the tum or site per se but the propens ity for local spread, which is highly influenced by the site and wh ich may res ult in a pos itive surgical margi n. This is even more apparent in cases of maxi llary sinus carci no ma; in our study, 100% of these tu mo rs sprea d locall y, and all affected patient s died of the disease. Spiro et al have also suggested that local spread is a major fac tor in decreasing the cure rate of patie nts with ACC. 3 Aggressive pr imary resect ion migh t be the only way to lower the mortality of pa tients wi th ACC in sites of prevalent local sp rea d. Rad iation may im pro ve the prognosis in patients with advance d disease. We did not find this to be mea ni ngful in KHA FIF, ANAVI, HAVIV, FIENME S SER, CALDERO N, MARSHAK Table 4 . Survival and mortality according to disease status among the 34 patients our patients, but we ca nnot draw any conclusions because of the selection bias-that is, patients with more adva nced disease were also treated with radiothera py. In another study, Spiro et alI reported that postoperative radiothera py conferre d no advantage, but others-? have shown that ACC is radiosensitive, although not necessarily radiocurable.? Radiation, therefore, might still be of value both in treating (postoperatively) locally adva nced disease and in treating patients who refuse surgical resection. As expected, both reg ional recurrence and distant metastasis were predictors of poor survival, and aggressive treatment of recurrences did not have an effect on outcome. Treatment delivered to the neck should be tailored to the specific site of origin, as has been proposed by Garden et al.'? In our series, there was not even 1 case of regio nal recurre nce among the 12 patients with parot id ACC, as opposed to 11 regional recurre nces in the remaining 22 patients (50.0%).We suggest careful evaluation and followup exa minations of the neck, including ultrasonography, in cases of ACC that originate in the minor salivary glands. Surgery should entail lymph node dissection, which can be limited to the area of maxi mal drainage; one such option is suprao mohyoid neck dissection for oral cavity tum ors. Again, we emp hasize the poor prognosis of our patients with regional recurrences (survival: 8.3%), indica ting the importance of prevention of regio nal recurrence.
In the specific case of ACC of the submandibular gland, we reco mmend surgical exc isio n of the submandibular triangle as the biopsy procedure. We cannot reco mmend elective treatment to the neck for these patients because of the small number of patient s in our study who had primary disease at that site. Obviously, more studies are needed to determine the pattern s of regional spread in ACC , as well as the preferred treatment modality and the role of preventi ve neck dissections.
Of the 6 patients in our series who receive d chemotherapy, 1 had early-stage disease and survived, and the other 5 had advanced disease and died of their disease despite aggress ive treatment. Thu s, in contrast to findings reported by Spiro et al,"we observed no advantage to adding chemotherapy to the treatment protocol for patients with advanced ACC. Asimilar observation was repor ted by Hill et ai, who found that the combination of cisplatinum and 5-fluorourac il resulted in no major improvement in survival REPRINTS Allen D . Williams, M .D. REPRINTS I found more.
"CompHealth found the perfect match for me. I like that kind of one-on-one atte ntion-they did an excellent job." In concl usion, the prognosis of patients whose ACC originates in the parotid gland is better than that of patients whose ACC arises in the minor salivary glands; the better outcome is attributable to the low rates of local spread and regional recurrence. Regional recurrences, whic h are most co mmo n in cases of A CC that arise in the minor salivary glands, carry an ominous outco me. Surge ry is the preferred primary treatm ent , and complete resection of the tumor with negative margins is indicated. In our series, no advantage was achieved from adjuva nt radiation or chemotherapy.
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